$5.7 Billion is the total value of Pentwater Capital Management LP's 123 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | New | HORIZON THERAPEUTICS PUB L | $402,812,853 | – | 3,539,656 | +100.0% | 7.07% | – |
| HZNP | New | HORIZON THERAPEUTICS PUB Lput | $315,419,460 | – | 2,771,700 | +100.0% | 5.53% | – |
| MAXR | New | MAXAR TECHNOLOGIES INC | $57,302,050 | – | 1,107,500 | +100.0% | 1.00% | – |
| DEN | New | DENBURY INC | $51,776,900 | – | 595,000 | +100.0% | 0.91% | – |
| AIMC | New | ALTRA INDL MOTION CORP | $40,331,250 | – | 675,000 | +100.0% | 0.71% | – |
| AJRD | New | AEROJET ROCKETDYNE HLDGS INC | $33,558,000 | – | 600,000 | +100.0% | 0.59% | – |
| DEN | New | DENBURY INCput | $24,365,600 | – | 280,000 | +100.0% | 0.43% | – |
| AJRD | New | AEROJET ROCKETDYNE HLDGS INCput | $16,779,000 | – | 300,000 | +100.0% | 0.29% | – |
| HZNP | New | HORIZON THERAPEUTICS PUB Lcall | $13,656,000 | – | 120,000 | +100.0% | 0.24% | – |
| QQQ | New | INVESCO QQQ TRput | $13,314,000 | – | 50,000 | +100.0% | 0.23% | – |
| AMC | New | AMC ENTMT HLDGS INCput | $11,843,700 | – | 2,910,000 | +100.0% | 0.21% | – |
| XOP | New | SPDR SER TRput | $10,191,000 | – | 75,000 | +100.0% | 0.18% | – |
| New | WARNER BROS DISCOVERY INCput | $9,906,600 | – | 1,045,000 | +100.0% | 0.17% | – | |
| COUP | New | COUPA SOFTWARE INC | $9,896,250 | – | 125,000 | +100.0% | 0.17% | – |
| AVEO | New | AVEO PHARMACEUTICALS INC | $8,244,596 | – | 551,478 | +100.0% | 0.14% | – |
| SPY | New | SPDR S&P 500 ETF TRcall | $7,648,600 | – | 20,000 | +100.0% | 0.13% | – |
| DIS | New | DISNEY WALT COput | $6,950,400 | – | 80,000 | +100.0% | 0.12% | – |
| EWA | New | ISHARES INCput | $5,557,500 | – | 250,000 | +100.0% | 0.10% | – |
| UNVR | New | UNIVAR SOLUTIONS INC | $5,247,000 | – | 165,000 | +100.0% | 0.09% | – |
| UNVR | New | UNIVAR SOLUTIONS INCput | $4,770,000 | – | 150,000 | +100.0% | 0.08% | – |
| ACI | New | ALBERTSONS COS INC | $2,696,200 | – | 130,000 | +100.0% | 0.05% | – |
| ALIT | New | ALIGHT INC | $2,090,000 | – | 250,000 | +100.0% | 0.04% | – |
| RBA | New | RITCHIE BROS AUCTIONEERScall | $2,024,050 | – | 35,000 | +100.0% | 0.04% | – |
| New | AMYLYX PHARMACEUTICALS INC | $1,293,250 | – | 35,000 | +100.0% | 0.02% | – | |
| STRO | New | SUTRO BIOPHARMA INCput | $1,131,200 | – | 140,000 | +100.0% | 0.02% | – |
| VIVO | New | MERIDIAN BIOSCIENCE INC | $996,300 | – | 30,000 | +100.0% | 0.02% | – |
| New | MOBILEYE GLOBAL INCput | $876,500 | – | 25,000 | +100.0% | 0.02% | – | |
| New | MOBILEYE GLOBAL INC | $876,500 | – | 25,000 | +100.0% | 0.02% | – | |
| New | PAYCOR HCM INC | $734,100 | – | 30,000 | +100.0% | 0.01% | – | |
| AMC | New | AMC ENTMT HLDGS INC | $752,543 | – | 184,900 | +100.0% | 0.01% | – |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $760,000 | – | 400,000 | +100.0% | 0.01% | – |
| ROG | New | ROGERS CORPput | $680,238 | – | 5,700 | +100.0% | 0.01% | – |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $660,000 | – | 6,000 | +100.0% | 0.01% | – |
| New | NCL CORP LTDnote 1.125% 2/15/27 | $687,800 | – | 1,000,000 | +100.0% | 0.01% | – | |
| RXDX | New | PROMETHEUS BIOSCIENCES INCput | $550,000 | – | 5,000 | +100.0% | 0.01% | – |
| RAPT | New | RAPT THERAPEUTICS INC | $495,000 | – | 25,000 | +100.0% | 0.01% | – |
| AZYO | New | AZIYO BIOLOGICS INC | $531,250 | – | 125,000 | +100.0% | 0.01% | – |
| STRO | New | SUTRO BIOPHARMA INCcall | $404,000 | – | 50,000 | +100.0% | 0.01% | – |
| HUYA | New | HUYA INC | $256,750 | – | 65,000 | +100.0% | 0.01% | – |
| New | BAUSCH PLUS LOMB CORP | $155,100 | – | 10,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BK OF AMERICA CORP | 42 | Q3 2023 | 0.1% |
| ESPERION THERAPEUTICS INC NE | 39 | Q2 2023 | 2.2% |
| SPDR S&P 500 ETF TR | 37 | Q2 2022 | 29.4% |
| SPDR S&P 500 ETF TR | 35 | Q3 2023 | 11.8% |
| SYNCHRONY FINL | 35 | Q3 2023 | 2.7% |
| WILLIAMS COS INC DEL | 35 | Q3 2023 | 1.4% |
| TURQUOISE HILL RESOURCES LTD | 30 | Q3 2020 | 11.0% |
| SPDR S&P 500 ETF TR | 28 | Q2 2022 | 7.3% |
| NXP SEMICONDUCTORS N V | 27 | Q3 2023 | 14.1% |
| SYNCHRONY FINL | 23 | Q4 2021 | 1.6% |
View Pentwater Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MONEYGRAM INTERNATIONAL INC | February 14, 2023 | 5,855,000 | 6.1% |
| SIERRA WIRELESS INC | February 14, 2023 | 2,190,000 | 5.6% |
| TURQUOISE HILL RESOURCES LTD. | November 21, 2022 | 30,358,382 | 15.1% |
| Poseida Therapeutics, Inc. | April 25, 2022 | 4,967,227 | 7.9% |
| COHERENT INC | February 11, 2022 | 1,402,000 | 5.7% |
| Nuance Communications, Inc. | February 11, 2022 | 17,340,000 | 5.4% |
| CORELOGIC, INC. | February 18, 2021 | 3,850,000 | 5.3% |
| Esperion Therapeutics, Inc. | February 16, 2021 | 722,580 | 2.6% |
| ACHILLION PHARMACEUTICALS INC | February 14, 2020 | 7,511,700 | 5.4% |
| SILVERBOW RESOURCES, INC. | February 14, 2020 | 501,698 | 4.3% |
View Pentwater Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| SC 13D/A | 2022-11-21 |
View Pentwater Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.